Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.
Identifieur interne : 003484 ( Main/Exploration ); précédent : 003483; suivant : 003485Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.
Auteurs : Krista M. Honkonen [Finlande] ; Mikko T. Visuri ; Tomi V. Tervala ; Paavo J. Halonen ; Mari Koivisto ; Markku T. L Hteenvuo ; Kari K. Alitalo ; Seppo Yl Herttuala ; Anne M. SaaristoSource :
- Annals of surgery [ 1528-1140 ] ; 2013.
Descripteurs français
- KwdFr :
- Adenoviridae, Animaux, Association thérapeutique, Facteur de croissance endothéliale vasculaire de type C (administration et posologie), Facteur de croissance endothéliale vasculaire de type C (génétique), Facteur de croissance endothéliale vasculaire de type C (pharmacologie), Facteur de croissance endothéliale vasculaire de type C (usage thérapeutique), Injections lymphatiques, Lymphangiogenèse (), Lymphoedème (), Modèles linéaires, Noeuds lymphatiques (transplantation), Régénération tissulaire guidée (), Régénération tissulaire guidée (effets indésirables), Résultat thérapeutique, Sus scrofa, Techniques de transfert de gènes, Thérapie génétique (), Thérapie génétique (effets indésirables), Vecteurs génétiques.
- MESH :
- administration et posologie : Facteur de croissance endothéliale vasculaire de type C.
- effets indésirables : Régénération tissulaire guidée, Thérapie génétique.
- génétique : Facteur de croissance endothéliale vasculaire de type C.
- pharmacologie : Facteur de croissance endothéliale vasculaire de type C.
- usage thérapeutique : Facteur de croissance endothéliale vasculaire de type C, Noeuds lymphatiques.
- Adenoviridae, Animaux, Association thérapeutique, Injections lymphatiques, Lymphangiogenèse, Lymphoedème, Modèles linéaires, Régénération tissulaire guidée, Résultat thérapeutique, Sus scrofa, Techniques de transfert de gènes, Thérapie génétique, Vecteurs génétiques.
English descriptors
- KwdEn :
- Adenoviridae, Animals, Combined Modality Therapy, Gene Transfer Techniques, Genetic Therapy (adverse effects), Genetic Therapy (methods), Genetic Vectors, Guided Tissue Regeneration (adverse effects), Guided Tissue Regeneration (methods), Injections, Intralymphatic, Linear Models, Lymph Nodes (transplantation), Lymphangiogenesis (drug effects), Lymphedema (therapy), Sus scrofa, Treatment Outcome, Vascular Endothelial Growth Factor C (administration & dosage), Vascular Endothelial Growth Factor C (genetics), Vascular Endothelial Growth Factor C (pharmacology), Vascular Endothelial Growth Factor C (therapeutic use).
- MESH :
- chemical , administration & dosage : Vascular Endothelial Growth Factor C.
- adverse effects : Genetic Therapy, Guided Tissue Regeneration.
- drug effects : Lymphangiogenesis.
- chemical , genetics : Vascular Endothelial Growth Factor C.
- methods : Genetic Therapy, Guided Tissue Regeneration.
- chemical , pharmacology : Vascular Endothelial Growth Factor C.
- chemical , therapeutic use : Vascular Endothelial Growth Factor C.
- therapy : Lymphedema.
- transplantation : Lymph Nodes.
- Adenoviridae, Animals, Combined Modality Therapy, Gene Transfer Techniques, Genetic Vectors, Injections, Intralymphatic, Linear Models, Sus scrofa, Treatment Outcome.
Abstract
Our objective was to define the optimal growth factor treatment to be used in combination with lymph node transfer to normalize lymphatic vascular anatomy.
DOI: 10.1097/SLA.0b013e31826ed043
PubMed: 23013803
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001F43
- to stream PubMed, to step Curation: 001F43
- to stream PubMed, to step Checkpoint: 001F43
- to stream Ncbi, to step Merge: 005165
- to stream Ncbi, to step Curation: 005165
- to stream Ncbi, to step Checkpoint: 005165
- to stream Main, to step Merge: 003490
- to stream Main, to step Curation: 003484
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.</title><author><name sortKey="Honkonen, Krista M" sort="Honkonen, Krista M" uniqKey="Honkonen K" first="Krista M" last="Honkonen">Krista M. Honkonen</name><affiliation wicri:level="1"><nlm:affiliation>A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio</wicri:regionArea><wicri:noRegion>Kuopio</wicri:noRegion></affiliation></author><author><name sortKey="Visuri, Mikko T" sort="Visuri, Mikko T" uniqKey="Visuri M" first="Mikko T" last="Visuri">Mikko T. Visuri</name></author><author><name sortKey="Tervala, Tomi V" sort="Tervala, Tomi V" uniqKey="Tervala T" first="Tomi V" last="Tervala">Tomi V. Tervala</name></author><author><name sortKey="Halonen, Paavo J" sort="Halonen, Paavo J" uniqKey="Halonen P" first="Paavo J" last="Halonen">Paavo J. Halonen</name></author><author><name sortKey="Koivisto, Mari" sort="Koivisto, Mari" uniqKey="Koivisto M" first="Mari" last="Koivisto">Mari Koivisto</name></author><author><name sortKey="L Hteenvuo, Markku T" sort="L Hteenvuo, Markku T" uniqKey="L Hteenvuo M" first="Markku T" last="L Hteenvuo">Markku T. L Hteenvuo</name></author><author><name sortKey="Alitalo, Kari K" sort="Alitalo, Kari K" uniqKey="Alitalo K" first="Kari K" last="Alitalo">Kari K. Alitalo</name></author><author><name sortKey="Yl Herttuala, Seppo" sort="Yl Herttuala, Seppo" uniqKey="Yl Herttuala S" first="Seppo" last="Yl Herttuala">Seppo Yl Herttuala</name></author><author><name sortKey="Saaristo, Anne M" sort="Saaristo, Anne M" uniqKey="Saaristo A" first="Anne M" last="Saaristo">Anne M. Saaristo</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23013803</idno><idno type="pmid">23013803</idno><idno type="doi">10.1097/SLA.0b013e31826ed043</idno><idno type="wicri:Area/PubMed/Corpus">001F43</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F43</idno><idno type="wicri:Area/PubMed/Curation">001F43</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001F43</idno><idno type="wicri:Area/PubMed/Checkpoint">001F43</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F43</idno><idno type="wicri:Area/Ncbi/Merge">005165</idno><idno type="wicri:Area/Ncbi/Curation">005165</idno><idno type="wicri:Area/Ncbi/Checkpoint">005165</idno><idno type="wicri:Area/Main/Merge">003490</idno><idno type="wicri:Area/Main/Curation">003484</idno><idno type="wicri:Area/Main/Exploration">003484</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.</title><author><name sortKey="Honkonen, Krista M" sort="Honkonen, Krista M" uniqKey="Honkonen K" first="Krista M" last="Honkonen">Krista M. Honkonen</name><affiliation wicri:level="1"><nlm:affiliation>A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio</wicri:regionArea><wicri:noRegion>Kuopio</wicri:noRegion></affiliation></author><author><name sortKey="Visuri, Mikko T" sort="Visuri, Mikko T" uniqKey="Visuri M" first="Mikko T" last="Visuri">Mikko T. Visuri</name></author><author><name sortKey="Tervala, Tomi V" sort="Tervala, Tomi V" uniqKey="Tervala T" first="Tomi V" last="Tervala">Tomi V. Tervala</name></author><author><name sortKey="Halonen, Paavo J" sort="Halonen, Paavo J" uniqKey="Halonen P" first="Paavo J" last="Halonen">Paavo J. Halonen</name></author><author><name sortKey="Koivisto, Mari" sort="Koivisto, Mari" uniqKey="Koivisto M" first="Mari" last="Koivisto">Mari Koivisto</name></author><author><name sortKey="L Hteenvuo, Markku T" sort="L Hteenvuo, Markku T" uniqKey="L Hteenvuo M" first="Markku T" last="L Hteenvuo">Markku T. L Hteenvuo</name></author><author><name sortKey="Alitalo, Kari K" sort="Alitalo, Kari K" uniqKey="Alitalo K" first="Kari K" last="Alitalo">Kari K. Alitalo</name></author><author><name sortKey="Yl Herttuala, Seppo" sort="Yl Herttuala, Seppo" uniqKey="Yl Herttuala S" first="Seppo" last="Yl Herttuala">Seppo Yl Herttuala</name></author><author><name sortKey="Saaristo, Anne M" sort="Saaristo, Anne M" uniqKey="Saaristo A" first="Anne M" last="Saaristo">Anne M. Saaristo</name></author></analytic><series><title level="j">Annals of surgery</title><idno type="eISSN">1528-1140</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenoviridae</term><term>Animals</term><term>Combined Modality Therapy</term><term>Gene Transfer Techniques</term><term>Genetic Therapy (adverse effects)</term><term>Genetic Therapy (methods)</term><term>Genetic Vectors</term><term>Guided Tissue Regeneration (adverse effects)</term><term>Guided Tissue Regeneration (methods)</term><term>Injections, Intralymphatic</term><term>Linear Models</term><term>Lymph Nodes (transplantation)</term><term>Lymphangiogenesis (drug effects)</term><term>Lymphedema (therapy)</term><term>Sus scrofa</term><term>Treatment Outcome</term><term>Vascular Endothelial Growth Factor C (administration & dosage)</term><term>Vascular Endothelial Growth Factor C (genetics)</term><term>Vascular Endothelial Growth Factor C (pharmacology)</term><term>Vascular Endothelial Growth Factor C (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adenoviridae</term><term>Animaux</term><term>Association thérapeutique</term><term>Facteur de croissance endothéliale vasculaire de type C (administration et posologie)</term><term>Facteur de croissance endothéliale vasculaire de type C (génétique)</term><term>Facteur de croissance endothéliale vasculaire de type C (pharmacologie)</term><term>Facteur de croissance endothéliale vasculaire de type C (usage thérapeutique)</term><term>Injections lymphatiques</term><term>Lymphangiogenèse ()</term><term>Lymphoedème ()</term><term>Modèles linéaires</term><term>Noeuds lymphatiques (transplantation)</term><term>Régénération tissulaire guidée ()</term><term>Régénération tissulaire guidée (effets indésirables)</term><term>Résultat thérapeutique</term><term>Sus scrofa</term><term>Techniques de transfert de gènes</term><term>Thérapie génétique ()</term><term>Thérapie génétique (effets indésirables)</term><term>Vecteurs génétiques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Vascular Endothelial Growth Factor C</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Facteur de croissance endothéliale vasculaire de type C</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Genetic Therapy</term><term>Guided Tissue Regeneration</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Lymphangiogenesis</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Régénération tissulaire guidée</term><term>Thérapie génétique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Vascular Endothelial Growth Factor C</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Facteur de croissance endothéliale vasculaire de type C</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Genetic Therapy</term><term>Guided Tissue Regeneration</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Facteur de croissance endothéliale vasculaire de type C</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Vascular Endothelial Growth Factor C</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Vascular Endothelial Growth Factor C</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="transplantation" xml:lang="en"><term>Lymph Nodes</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Facteur de croissance endothéliale vasculaire de type C</term><term>Noeuds lymphatiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adenoviridae</term><term>Animals</term><term>Combined Modality Therapy</term><term>Gene Transfer Techniques</term><term>Genetic Vectors</term><term>Injections, Intralymphatic</term><term>Linear Models</term><term>Sus scrofa</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adenoviridae</term><term>Animaux</term><term>Association thérapeutique</term><term>Injections lymphatiques</term><term>Lymphangiogenèse</term><term>Lymphoedème</term><term>Modèles linéaires</term><term>Régénération tissulaire guidée</term><term>Résultat thérapeutique</term><term>Sus scrofa</term><term>Techniques de transfert de gènes</term><term>Thérapie génétique</term><term>Vecteurs génétiques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Our objective was to define the optimal growth factor treatment to be used in combination with lymph node transfer to normalize lymphatic vascular anatomy.</div></front></TEI><affiliations><list><country><li>Finlande</li></country></list><tree><noCountry><name sortKey="Alitalo, Kari K" sort="Alitalo, Kari K" uniqKey="Alitalo K" first="Kari K" last="Alitalo">Kari K. Alitalo</name><name sortKey="Halonen, Paavo J" sort="Halonen, Paavo J" uniqKey="Halonen P" first="Paavo J" last="Halonen">Paavo J. Halonen</name><name sortKey="Koivisto, Mari" sort="Koivisto, Mari" uniqKey="Koivisto M" first="Mari" last="Koivisto">Mari Koivisto</name><name sortKey="L Hteenvuo, Markku T" sort="L Hteenvuo, Markku T" uniqKey="L Hteenvuo M" first="Markku T" last="L Hteenvuo">Markku T. L Hteenvuo</name><name sortKey="Saaristo, Anne M" sort="Saaristo, Anne M" uniqKey="Saaristo A" first="Anne M" last="Saaristo">Anne M. Saaristo</name><name sortKey="Tervala, Tomi V" sort="Tervala, Tomi V" uniqKey="Tervala T" first="Tomi V" last="Tervala">Tomi V. Tervala</name><name sortKey="Visuri, Mikko T" sort="Visuri, Mikko T" uniqKey="Visuri M" first="Mikko T" last="Visuri">Mikko T. Visuri</name><name sortKey="Yl Herttuala, Seppo" sort="Yl Herttuala, Seppo" uniqKey="Yl Herttuala S" first="Seppo" last="Yl Herttuala">Seppo Yl Herttuala</name></noCountry><country name="Finlande"><noRegion><name sortKey="Honkonen, Krista M" sort="Honkonen, Krista M" uniqKey="Honkonen K" first="Krista M" last="Honkonen">Krista M. Honkonen</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003484 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003484 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23013803
|texte= Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23013803" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |